EUVIMEDEUVIMED entdecken
Klinische Studie (Phase II)Multizentrische Studie

Pharmacokinetics and pharmacodynamics of an anti-CSF1 receptor antibody in the intra-articular treatment of tenosynovial giant cell tumor

Michiel van de Sande, Kirk Johnson, Kirsten van Langevelde, Thomas Scharschmidt, Laman Alani, Dorothy Nguyen, Tiffany Nguyen, Chinglin Lai, Hans Gelderblom

European Journal of Cancer · 2025

DOI: 10.1016/j.ejca.2025.115756 ↗

Kurz gefasst

Klinische Studie (Phase II) in der Zeitschrift European Journal of Cancer, 2025. Verfasst von Michiel van de Sande und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedic Surgery, Leiden University Medical Center, Leiden, the Netherlands. Hauptthemen laut MEDLINE: Giant Cell Tumor of Tendon Sheath, Receptors, Granulocyte-Macrophage Colony-Stimulating Factor, Antibodies, Monoclonal, Antineoplastic Agents, Immunological. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 32 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Giant Cell Tumor of Tendon SheathReceptors, Granulocyte-Macrophage Colony-Stimulating FactorAntibodies, MonoclonalAntineoplastic Agents, ImmunologicalAnimalsHumansMiddle AgedMaleFemaleInjections, Intra-ArticularAdultAgedMacaca fascicularisReceptor, Macrophage Colony-Stimulating Factor

Stichwörter der Autor:innen

Intra-articularNovel CSF1R-targeted therapeuticRECIST and PROsSarcomaTenosynovial giant cell tumorTranslational monkey to human

Substanzen

Receptors, Granulocyte-Macrophage Colony-Stimulating FactorCSF1R protein, humanAntibodies, MonoclonalAntineoplastic Agents, ImmunologicalReceptor, Macrophage Colony-Stimulating Factor

Autor:innen und Institutionen

  • Department of Orthopedic Surgery, Leiden University Medical Center, Leiden, the Netherlands.
  • AmMax Bio, Redwood City, CA, United States. Electronic address: kirkjohnson@comcast.net.
  • Department of Radiology, Leiden University Medical Center, Leiden, the Netherlands.
  • Pediatric Orthopedic Oncology Program at Nationwide Children's Hospital, United States; The Ohio State University Medical Center and James Cancer Hospital, United States.
  • AmMax Bio, Redwood City, CA, United States.
  • Leiden University Medical Center, Leiden, the Netherlands.

Zitieren

APA

van de Sande, M., Johnson, K., van Langevelde, K., Scharschmidt, T., Alani, L., Nguyen, D., Nguyen, T., Lai, C., & Gelderblom, H. (2025). Pharmacokinetics and pharmacodynamics of an anti-CSF1 receptor antibody in the intra-articular treatment of tenosynovial giant cell tumor. European Journal of Cancer. https://doi.org/10.1016/j.ejca.2025.115756

Vancouver

van de Sande M, Johnson K, van Langevelde K, Scharschmidt T, Alani L, Nguyen D, et al. Pharmacokinetics and pharmacodynamics of an anti-CSF1 receptor antibody in the intra-articular treatment of tenosynovial giant cell tumor. European Journal of Cancer. 2025. doi:10.1016/j.ejca.2025.115756

BibTeX
@article{vandeSande2025,
  author = {van de Sande, Michiel and Johnson, Kirk and van Langevelde, Kirsten and Scharschmidt, Thomas and Alani, Laman and Nguyen, Dorothy and Nguyen, Tiffany and Lai, Chinglin and Gelderblom, Hans},
  title = {Pharmacokinetics and pharmacodynamics of an anti-CSF1 receptor antibody in the intra-articular treatment of tenosynovial giant cell tumor},
  journal = {European Journal of Cancer},
  year = {2025},
  doi = {10.1016/j.ejca.2025.115756}
}
Kostenlos starten →